Probiotics in food

Chemical and Functional Properties of Food Components, Third Edition

Volumn , Issue , 2006, Pages 413-426

  Bielecka, Maria ^a  

^a POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; FUNCTIONAL FOOD; HEALTH RISKS; NUTRITION;

ACTIVE INGREDIENTS; CONSUMER AWARENESS; FOOD INDUSTRIES; HEALTH BENEFITS; NUTRITIONAL BENEFITS; PROBIOTIC BACTERIA; RELATED PRODUCTS; THERAPEUTIC BENEFITS;

FOOD MICROBIOLOGY;

EID: 80054707461     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (46)

1. Adams, M.R. and Marteau, P., 1995, On the safety of lactic acid bacteria from food, Int. J. Food Microbiol., 27, 263.
2. Aquirre, M. and Collins, M.D., 1993, Lactic acid bacteria and human clinical infection, J. Appl. Bacteriol., 75, 95.
3. Arthur, M., Reynolds, P., and Courvalin, P., 1996, Glycopeptide resistance in enterococci, Trends Microbiol., 4, 401.
4. Berg, R.D., 1998, Probiotics, prebiotics or “conbiotics”? Trends in Microbiol., 6, 3, 89.
5. Biedrzycka, E., Bielecka, M., Wróblewska, B., Jędrychowski, L., Zduńczyk, Z., and Haros, C.M., 2003, Immunostimulative activity of probiotic Bifidobacterium strains determined in vivo using ELISA method, Pol. J. Food Nutr. Sci., 12, SI 1, 20.
6. Bielecka, M., Biedrzycka, E., and Biedrzycka, El., 2000a, Isolation and identification of bifidobacterial strains, Med. Sci. Monitor, Int. Med. J. Exp. Clin. Res., 6 (Suppl. 3), 123.
7. Bielecka, M., Biedrzycka, E., and Majkowska, A., 2000b, Selection of bifidobacterial strains capable for colonisation of gastrointestinal tract, Med. Sci. Monitor, Int. Med. J. Exp. Clin. Res., 6 (Suppl. 3), 123.
8. Bielecka, M. et al., 1998, Interaction of Bifidobacterium and Salmonella, Int. J. Food Microbiol., 45, 151.
9. Bielecka, M. et al., 2002, The influence of bifidobacteria on pathomorphological pattern and microflora of gastrointestinal tract in non-infected and Salmonella-administered rats, Br. J. Nutr., 88, Suppl. 1, S109.
10. Bouhnik, Y. et al., 1996, Effects of Bifidobacterium sp. fermented milk ingested with and without inulin on colonic Bifidobacteria and enzymatic activities in healthy humans, Eur. J. Clin. Nutr. 50, 269.
11. Cai, Y., Matsumoto, M., and Benno, Y., 2000, Bifidobacterium lactis Meile et al. 1997 is a subjective synonym of Bifidobacterium animalis (Mitsuoka 1969) Scardovi and Trovatelli 1974, Microbiol. Immunol., 44, 815.
12. Corthier, G., Dubos, F., and Raibaud, P., 1985, Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria, Appl. Environ. Microbiol., 49, 250.
13. De Petrino, S.F. et al., 1995, Protective ability of certain lactic acid bacteria against an infection with Candida albicans in a mouse immunosuppression model by corticoid, Food Agricult. Immunol., 7, 365.
14. Fonden, R. et al., 2000, Effect of fermented dairy products on intestinal microflora, human nutrition and health: current knowledge and future perspectives, Bull. IDF, 352, 1.
15. Gibson, G.R., 1998, Dietary modulation of the human gut microflora using prebiotics, Br. J. Nutr., 80 (Suppl. 2), S209.
16. Gill, H.S., 1998, Stimulation of the immune system by lactic cultures, Int. Dairy J., 8, 535.
17. Giraffa, G., Carminati, D., and Neviani, E., 1997, Enterococci isolated from dairy products:a review of risk and potential technological use, J. Food Prot., 60, 732.
18. Goldin, B.R. and Gorbach, S.L., 1992, Probiotics for humans, in Probiotics: The Scientific Basis, Fuller, R., Ed., Chapman & Hall, London, p. 355.
19. Guarner, F. and Schaafsma, G.J., 1998, Probiotics, Int. J. Food Microbiol., 39, 237.
20. Huis in’t Veld, J.H.J., Havenaar, R., and Marteau, P., 1994, Establishing a scientific basis for probiotic R&D, Trends Biotechnol., 12, 6.
21. Jett, B.D., Huycke, M.M., and Gilmore, M.S., 1994, Virulence of enterococci, Clin. Microbiol. Rev., 7, 462.
22. Kaila, M. et al., 1992, Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain, Pediatr. Res., 32, 141.
23. Lilly, D.M. and Stillwell, R.H., 1965, Probiotics. Growth promoting factors produced by micro-organisms, Science, 147, 747.
24. Marteau, P. and Rambaud, J.C., 1993, Potential of using lactic acid bacteria for therapy and immunomodulation in man, FEMS Microbiol. Rev., 12, 207.
25. Matsumoto, M. et al., 2000, Effect of Bifidobacterium lactis LKM 512 yoghurt on fecal microflora in middle to old aged persons, Microb. Ecol. Health Dis., 12, 77.
26. Meile, L. et al., 1997, Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk, Syst. Appl. Microbiol., 20, 57.
27. Mitsuoka, T., 1996, Intestinal flora and human health, Asia Pacific J. Clin. Nutr., 5, 1, 2.
28. Molin, G. et al., 1993, Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines, J. Appl. Bacteriol., 74, 314.
29. Nader de Macias, M.E. et al., 1992, Inhibition of Shigella sonnei by Lactobacillus casei and Lact. acidophilus, J. Appl. Bacteriol., 73, 407.
30. Noble, W.C., Virani, Z., and Cree, R.G.A., 1992, Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus, FEMS Microbiol. Lett., 93, 195.
31. Ouwehand, A.C. et al., 1999, Probiotics: mechanisms and established effects, Int. Dairy J., 9, 43.
32. Paubert-Braquet, M. et al., 1995, Enhancement of host resistance against Salmonella typhimurium in mice fed a diet supplemented with yoghurt or milks fermented with various Lactobacillus casei strains, Int. J. Immunother., 11, 153.
33. Perdigon, G. and Alvarez, S., 1992, Probiotics and the immune state, in Probiotics, Fuller, R., Ed., Chapman & Hall, London, p. 146.
34. Perdigon, G. et al., 1990, Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus, J. Dairy Res., 57, 255.
35. Portier, A. et al., 1993, Fermented milks and increased antibody responses against cholera in mice, Int. J. Immunother., 9, 217.
36. Roy, D. and Sirois, S., 2000, Molecular differentiation of Bifidobacterium species with amplified ribosomal DNA restriction analysis and alignment of short regions of the ldh gene, FEMS Microbiol. Lett., 191, 17.
37. Roy, D., Ward, P., and Champagne, G., 1996, Differentiation of bifidobacteria by use of pulsed-field gel electrophoresis and polymeraze chain reaction, Int. J. Food Microbiol., 29, 11.
38. Salminen, S. et al., 1998a, Lactic acid bacteria in health and disease, in Lactic Acid Bacteria:Microbiology and Functional Aspects, 2nd ed., Salminen, S. and von Wright, A., Eds., Marcel Dekker, New York, p. 211.
39. Salminen, S., Isolauri, E., and Salminen, E., 1996, Clinical uses of probiotics for stabilising the gut mucosal barrier: successful strains and future challenges, Antonie van Leeuwenhoek, 70, 251.
40. Salminen, S. et al., 1998b, Demonstration of safety of probiotics-a review, Int. J. Food Microbiol., 44, 93.
41. Sanders, M.E. and Huis in’t Veld, J.H.J., 1999, Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labelling issues, Antonie van Leeuwenhoek, 76, 293.
42. Saxelin, M., 1997, Lactobacillus GG-a human probiotic strain with thorough clinical documentation, Food Rev. Int., 13, 293.
43. Schiffrin, E.J. et al., 1997, Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection, Am. J. Clin. Nutr., 66, 515S.
44. Schrezenmeir, J. and de Vrese, M., 2001, Probiotics, prebiotics, and synbiotics-approaching a definition, Am. J. Clin. Nutr., 73, 361S.
45. Targan, R. and Shanahan, F., 1994, Inflammatory Bowel Disease from Bench to Bedside, Williams & Wilkins, Baltimore, MD.
46. Vaughan, E.E., Mollet, B., and de Vos, W.M., 1999, Functionality of probiotics and intestinal lactobacilli: light in the intestinal tract tunnel, Curr. Opin. Biotech., 10, 505.